Cantor Fitzgerald Reiterates Sell on bluebird bio (BLUE) Following ASH Abstracts
Tweet Send to a Friend
Cantor Fitzgerald analyst Elemer Piros reiterated a Sell rating and $37 price target on bluebird bio (NASDAQ: BLUE) following this ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
